Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis

Background: The benefit–risk profile of perioperative corticosteroids in pediatric patients undergoing cardiac surgery remains controversial.Objective: To investigate the influence of perioperative corticosteroids on the postoperative mortality and clinical outcomes in pediatric patients undergoing...

Full description

Bibliographic Details
Main Authors: Yinan Li, Qipeng Luo, Xie Wu, Yuan Jia, Fuxia Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.00350/full
_version_ 1818445842538823680
author Yinan Li
Qipeng Luo
Xie Wu
Yuan Jia
Fuxia Yan
author_facet Yinan Li
Qipeng Luo
Xie Wu
Yuan Jia
Fuxia Yan
author_sort Yinan Li
collection DOAJ
description Background: The benefit–risk profile of perioperative corticosteroids in pediatric patients undergoing cardiac surgery remains controversial.Objective: To investigate the influence of perioperative corticosteroids on the postoperative mortality and clinical outcomes in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass.Methods: We conducted a systematic search using MEDLINE, EMBASE, and Cochrane Database through August 31, 2019. We included randomized controlled trials comparing perioperative corticosteroids with other clinical interventions, placebo, or no treatment in children between 0 and 18 years of age undergoing cardiac surgery. The primary outcome of interest was all-cause in-hospital mortality. The secondary outcomes were length of intensive care unit stay (LOIS), duration of mechanical ventilation (DMV), postoperative insulin therapy, postoperative low cardiac output syndrome (LCOS), postoperative infection, maximal temperature (Tmax) in the first 24 h postoperatively, urine output (UO) in the first 24 h postoperatively, serum lactate at postoperative day (POD) 1, blood glucose at POD 1, vasoactive inotrope score (VIS) at POD 1, and postoperative acute kidney injury (AKI). Study quality was assessed using the Cochrane Risk of Bias Assessment Tool.Results: Our analysis included 17 studies and 848 pediatric patients. The data demonstrated that children receiving corticosteroids showed no significant difference on the all-cause in-hospital mortality with a fixed-effect model (RR = 0.59, 95% CI = 0.28–1.25, P = 0.55) compared with controls. For the secondary outcomes, corticosteroids had a statistically significant reduction on the VIS at POD1 (MD = −2.04, 95% CI = −3.96 −0.12, P = 0.04), while it might be significantly associated with an increased blood glucose at POD1 (MD = 1.38, 95% CI = 0.68–2.09, P = 0.0001) and a 2.69-fold higher risk of postoperative insulin therapy (RR = 2.69, 95% CI = 1.37–5.27, P = 0.004). No statistical significance was shown in other secondary outcomes.Conclusion: Perioperative corticosteroids might not significantly improve clinical outcomes identified as mortality, LOIS, DMV, AKI, and LCOS other than VIS at POD1. However, it might increase the blood glucose and episodes of insulin therapy. Perioperative corticosteroids to attenuate the inflammatory response are not supported by available evidence from our study. Further results from ongoing randomized controlled trials with a larger sample size are required.
first_indexed 2024-12-14T19:38:15Z
format Article
id doaj.art-bedd8c0b479a436cad26ad61e324e23f
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-14T19:38:15Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-bedd8c0b479a436cad26ad61e324e23f2022-12-21T22:49:47ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602020-07-01810.3389/fped.2020.00350515497Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-AnalysisYinan LiQipeng LuoXie WuYuan JiaFuxia YanBackground: The benefit–risk profile of perioperative corticosteroids in pediatric patients undergoing cardiac surgery remains controversial.Objective: To investigate the influence of perioperative corticosteroids on the postoperative mortality and clinical outcomes in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass.Methods: We conducted a systematic search using MEDLINE, EMBASE, and Cochrane Database through August 31, 2019. We included randomized controlled trials comparing perioperative corticosteroids with other clinical interventions, placebo, or no treatment in children between 0 and 18 years of age undergoing cardiac surgery. The primary outcome of interest was all-cause in-hospital mortality. The secondary outcomes were length of intensive care unit stay (LOIS), duration of mechanical ventilation (DMV), postoperative insulin therapy, postoperative low cardiac output syndrome (LCOS), postoperative infection, maximal temperature (Tmax) in the first 24 h postoperatively, urine output (UO) in the first 24 h postoperatively, serum lactate at postoperative day (POD) 1, blood glucose at POD 1, vasoactive inotrope score (VIS) at POD 1, and postoperative acute kidney injury (AKI). Study quality was assessed using the Cochrane Risk of Bias Assessment Tool.Results: Our analysis included 17 studies and 848 pediatric patients. The data demonstrated that children receiving corticosteroids showed no significant difference on the all-cause in-hospital mortality with a fixed-effect model (RR = 0.59, 95% CI = 0.28–1.25, P = 0.55) compared with controls. For the secondary outcomes, corticosteroids had a statistically significant reduction on the VIS at POD1 (MD = −2.04, 95% CI = −3.96 −0.12, P = 0.04), while it might be significantly associated with an increased blood glucose at POD1 (MD = 1.38, 95% CI = 0.68–2.09, P = 0.0001) and a 2.69-fold higher risk of postoperative insulin therapy (RR = 2.69, 95% CI = 1.37–5.27, P = 0.004). No statistical significance was shown in other secondary outcomes.Conclusion: Perioperative corticosteroids might not significantly improve clinical outcomes identified as mortality, LOIS, DMV, AKI, and LCOS other than VIS at POD1. However, it might increase the blood glucose and episodes of insulin therapy. Perioperative corticosteroids to attenuate the inflammatory response are not supported by available evidence from our study. Further results from ongoing randomized controlled trials with a larger sample size are required.https://www.frontiersin.org/article/10.3389/fped.2020.00350/fullcorticosteroidchildrencardiac surgerymeta-analysiscongenital heart defect
spellingShingle Yinan Li
Qipeng Luo
Xie Wu
Yuan Jia
Fuxia Yan
Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
Frontiers in Pediatrics
corticosteroid
children
cardiac surgery
meta-analysis
congenital heart defect
title Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
title_full Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
title_fullStr Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
title_full_unstemmed Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
title_short Perioperative Corticosteroid Therapy in Children Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
title_sort perioperative corticosteroid therapy in children undergoing cardiac surgery a systematic review and meta analysis
topic corticosteroid
children
cardiac surgery
meta-analysis
congenital heart defect
url https://www.frontiersin.org/article/10.3389/fped.2020.00350/full
work_keys_str_mv AT yinanli perioperativecorticosteroidtherapyinchildrenundergoingcardiacsurgeryasystematicreviewandmetaanalysis
AT qipengluo perioperativecorticosteroidtherapyinchildrenundergoingcardiacsurgeryasystematicreviewandmetaanalysis
AT xiewu perioperativecorticosteroidtherapyinchildrenundergoingcardiacsurgeryasystematicreviewandmetaanalysis
AT yuanjia perioperativecorticosteroidtherapyinchildrenundergoingcardiacsurgeryasystematicreviewandmetaanalysis
AT fuxiayan perioperativecorticosteroidtherapyinchildrenundergoingcardiacsurgeryasystematicreviewandmetaanalysis